![Hans Bunschoten](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hans Bunschoten
Geschäftsführer bei ViroClinics Biosciences BV
Aktive Positionen von Hans Bunschoten
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ViroClinics Biosciences BV
![]() ViroClinics Biosciences BV Pharmaceuticals: MajorHealth Technology ViroClinics Biosciences BV engages in the provision of diagnostic and clinical trial solutions. It offers research and development, preclinical, clinical trial operation, diagnostic testing, virus discovery, and quality assurance services. The company was founded by Albert Osterhaus in 2001 and is headquartered in Rotterdam, the Netherlands. | Geschäftsführer | 01.01.2008 | - |
Karriereverlauf von Hans Bunschoten
Ehemalige bekannte Positionen von Hans Bunschoten
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Organon BioSciences NV
![]() Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands. | Corporate Officer/Principal | - | - |
Ausbildung von Hans Bunschoten
University of Utrecht | Doctorate Degree |
Statistik
International
Niederlande | 4 |
Operativ
Chief Operating Officer | 1 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
ViroClinics Biosciences BV
![]() ViroClinics Biosciences BV Pharmaceuticals: MajorHealth Technology ViroClinics Biosciences BV engages in the provision of diagnostic and clinical trial solutions. It offers research and development, preclinical, clinical trial operation, diagnostic testing, virus discovery, and quality assurance services. The company was founded by Albert Osterhaus in 2001 and is headquartered in Rotterdam, the Netherlands. | Health Technology |
Organon BioSciences NV
![]() Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands. | Health Technology |
- Börse
- Insiders
- Hans Bunschoten
- Erfahrung